307 related articles for article (PubMed ID: 25696830)
21. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in the treatment of older individuals with acute myeloid leukemia: 2014.
Michaelis LC; Erba HP
Curr Opin Hematol; 2015 Mar; 22(2):108-15. PubMed ID: 25603478
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia.
Ferrara F; Annunziata M; Copia C; Magrin S; Mele G; Mirto S
Haematologica; 1998 Feb; 83(2):126-31. PubMed ID: 9549923
[TBL] [Abstract][Full Text] [Related]
24. Advances in the management of acute myeloid leukemia in older adult patients.
Rogers BB
Oncol Nurs Forum; 2010 May; 37(3):E168-79. PubMed ID: 20439202
[TBL] [Abstract][Full Text] [Related]
25. Primary treatment of acute myeloid leukemia (non M3) in elderly: a review.
Ramamoorthy K; Ramesh P; Al Bahar S
Gulf J Oncolog; 2008 Jul; (4):19-26. PubMed ID: 20084771
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia in the elderly: conventional and novel treatment approaches.
Craig CM; Schiller GJ
Blood Rev; 2008 Jul; 22(4):221-34. PubMed ID: 18433953
[TBL] [Abstract][Full Text] [Related]
27. Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia.
Michaelis LC; Klepin HD; Walter RB
Expert Opin Pharmacother; 2018 Jun; 19(8):865-882. PubMed ID: 29697000
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
Song LX; Xu L; Li X; Chang CK; Zhang Y; Wu LY; He Q; Zhang QX; Li X
Ann Hematol; 2012 Dec; 91(12):1879-86. PubMed ID: 22895556
[TBL] [Abstract][Full Text] [Related]
29. The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.
Tasaki T; Yamauchi T; Matsuda Y; Takai M; Ookura M; Lee S; Tai K; Ikegaya S; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Anticancer Res; 2014 Oct; 34(10):5631-6. PubMed ID: 25275066
[TBL] [Abstract][Full Text] [Related]
30. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.
Isidori A; Venditti A; Maurillo L; Buccisano F; Loscocco F; Manduzio P; Sparaventi G; Amadori S; Visani G
Expert Rev Hematol; 2013 Dec; 6(6):767-84. PubMed ID: 24219553
[TBL] [Abstract][Full Text] [Related]
31. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.
Deschler B; de Witte T; Mertelsmann R; Lübbert M
Haematologica; 2006 Nov; 91(11):1513-22. PubMed ID: 17082009
[TBL] [Abstract][Full Text] [Related]
32. The safety of treatment options for elderly people with acute myeloid leukemia.
Thomas X; Le Jeune C
Expert Opin Drug Saf; 2016 May; 15(5):635-45. PubMed ID: 26943698
[TBL] [Abstract][Full Text] [Related]
33. An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia.
Kaur I; Constance JE; Kosak KM; Spigarelli MG; Sherwin CM
Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):53-65. PubMed ID: 25488904
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
35. What is the optimal induction strategy for older patients?
Estey E
Best Pract Res Clin Haematol; 2011 Dec; 24(4):515-22. PubMed ID: 22127314
[TBL] [Abstract][Full Text] [Related]
36. Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG).
Wedding U; Bokemeyer C; Meran JG; ; ;
Onkologie; 2004 Feb; 27(1):72-82. PubMed ID: 15007253
[TBL] [Abstract][Full Text] [Related]
37. Acute myelogenous leukemia.
Shipley JL; Butera JN
Exp Hematol; 2009 Jun; 37(6):649-58. PubMed ID: 19463767
[TBL] [Abstract][Full Text] [Related]
38. The role of hypomethylating agents in the treatment of elderly patients with AML.
Al-Ali HK; Jaekel N; Niederwieser D
J Geriatr Oncol; 2014 Jan; 5(1):89-105. PubMed ID: 24484723
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
Martínez-Cuadrón D; Montesinos P; Oriol A; Salamero O; Vidriales B; Bergua J; Herrera P; Vives S; Sanz J; Carpio C; Rodríguez-Veiga R; Moscardó F; Sanz MA
Ann Hematol; 2014 Jan; 93(1):43-6. PubMed ID: 24081577
[TBL] [Abstract][Full Text] [Related]
40. Design and conduct of a double-blind, placebo-controlled trial of daunorubicin and cytarabine with or without granulocyte colony-stimulating factor in elderly patients with acute myeloid leukemia: a Southwest Oncology Group study.
Godwin J
J Natl Cancer Inst Monogr; 1995; (19):31-5. PubMed ID: 7577202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
